Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Vertex Pharma | Mexico | Healthcare | Biotechnology & Medical Research | MX$2.49T | -253.6x | 2.17 | MX$9,692.79 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moderna | Mexico | Healthcare | Biotechnology & Medical Research | MX$258.01B | -5.6x | -0.19 | MX$671.79 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CRISPR Therapeutics AG | Mexico | Healthcare | Biotechnology & Medical Research | MX$69.71B | -13.7x | -0.42 | MX$881 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
FibroGen | Mexico | Healthcare | Biotechnology & Medical Research | MX$1.04B | -0.4x | -0.01 | MX$10.25 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |